moxalactam has been researched along with Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y; Fujimoto, S; Hara, M; Kohi, F; Lai, M; Oda, Y; Ohmoto, E; Takahashi, I; Takaoka, K; Uchida, K | 1 |
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
| Elliott, CR; Pater, JL | 1 |
| Belch, A; Bow, EJ; Chow, A; Feld, R; Louie, TJ; Mandell, L; Miedzinski, L; Pater, J; Rachlis, A; Robson, HG | 1 |
2 trial(s) available for moxalactam and Leukemia
| Article | Year |
|---|---|
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Cloxacillin; Drug Therapy, Combination; Fever; Humans; Infection Control; Leukemia; Lymphoma; Moxalactam; Multicenter Studies as Topic; Neoplasms; Neutropenia; Prognosis; Random Allocation; Tobramycin | 1988 |
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Canada; Clinical Trials as Topic; Drug Therapy, Combination; Female; Granulocytes; Humans; Leukemia; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Penicillin Resistance; Prognosis; Random Allocation; Ticarcillin; Tobramycin | 1985 |
2 other study(ies) available for moxalactam and Leukemia
| Article | Year |
|---|---|
[Clinical effects of ceftizoxime and latamoxef on infections in acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Ceftizoxime; Drug Evaluation; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Moxalactam; Neutrophils | 1983 |
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |